Medicine
Sevelamer 800 mg tablet
Sevelamer 800 mg tablet is a generic prescription medicine for parenteral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Sevelamer
- Brand
- Sold under the generic name
- Strength
- 800 mg
- Dosage form
- Tablet
- Route
- Parenteral
- Packs
- 10 blister pack, 50 blister pack
- Manufacturers
- Cardinal HealthMajor Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from moisture and store in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AE02 Sevelamer
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 August 2024
- Identifiers
- RxCUI 857224DailyMed set ID 0500034d-458c-42c5-918d-9acd22f0c28b, c13532a7-4c56-4084-839d-3dcfd4dc30f8NDC 0904-7209, 55154-2647Application ANDA204724
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 blister pack in 1 bag / 1 tablet, film coated in 1 blister pack | 55154-2647-0 | Cardinal Health | 25 February 2025 |
| 50 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-7209-06 | Major Pharmaceuticals | 19 August 2024 |
| 1000 tablet, film coated in 1 bottle | 68382-824-10 | — | 17 September 2020 |
| 270 tablet, film coated in 1 bottle | 68382-824-27 | — | 17 September 2020 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 68382-824-77 | — | 17 September 2020 |
| 180 tablet, film coated in 1 bottle | 70710-2058-8 | — | 1 March 2025 |
| 30 tablet, film coated in 1 bottle | 70710-2170-3 | — | 1 April 2026 |
| 180 tablet, film coated in 1 bottle | 70710-2170-7 | — | 1 April 2026 |
| 270 tablet, film coated in 1 bottle | 70710-2170-8 | — | 1 April 2026 |
| 1000 tablet, film coated in 1 bottle | 70771-1520-0 | — | 17 September 2020 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 70771-1520-4 | — | 17 September 2020 |
| 270 tablet, film coated in 1 bottle | 70771-1520-8 | — | 17 September 2020 |
| 180 tablet, film coated in 1 bottle | 59651-088-18 | — | 11 July 2023 |
| 180 tablet, film coated in 1 bottle | 65862-921-18 | — | 17 July 2017 |
| 270 tablet, film coated in 1 bottle | 65862-921-27 | — | 17 July 2017 |
| 30 tablet, film coated in 1 bottle | 65862-921-30 | — | 17 July 2017 |
| 270 tablet, film coated in 1 bottle | 69097-893-93 | — | 26 October 2017 |
| 270 tablet, film coated in 1 bottle | 69097-967-93 | — | 8 August 2019 |
| 14 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 33342-215-56 | — | 31 October 2025 |
| 180 tablet, film coated in 1 bottle | 33342-215-57 | — | 13 March 2026 |
| 270 tablet, film coated in 1 bottle | 33342-215-58 | — | 19 April 2023 |
| 30 tablet, film coated in 1 bottle | 33342-242-07 | — | 26 May 2023 |
| 180 tablet, film coated in 1 bottle | 33342-242-57 | — | 26 May 2023 |
| 25 blister pack in 1 carton / 4 tablet, film coated in 1 blister pack | 55111-789-11 | — | 12 December 2018 |
| 270 tablet, film coated in 1 bottle | 55111-789-27 | — | 29 September 2017 |
| 30 tablet, film coated in 1 bottle | 55111-789-30 | — | 29 September 2017 |
| 90 tablet, film coated in 1 bottle | 55111-789-90 | — | 29 September 2017 |
| 180 tablet, film coated in 1 bottle | 68462-447-18 | — | 8 February 2019 |
| 30 tablet, film coated in 1 bottle | 68462-447-30 | — | 8 February 2019 |
| 180 tablet in 1 bottle | 70748-173-26 | — | 25 February 2022 |
| 30 tablet in 1 bottle | 64380-872-04 | — | 2 July 2024 |
| 270 tablet in 1 bottle | 64380-872-67 | — | 2 July 2024 |
| 270 tablet, film coated in 1 bottle | 76282-407-27 | — | 8 November 2017 |
| 270 tablet, film coated in 1 bottle | 76282-664-27 | — | 8 August 2019 |
| 270 tablet, film coated in 1 bottle | 0955-1050-27 | — | 1 February 2018 |
| 270 tablet, film coated in 1 bottle | 0955-1057-30 | — | 14 July 2023 |
| 270 tablet in 1 bottle | 11788-116-07 | — | 15 December 2025 |
| 30 tablet, film coated in 1 bottle | 65162-058-03 | — | 13 July 2023 |
| 60 tablet, film coated in 1 bottle | 65162-058-06 | — | 13 July 2023 |
| 90 tablet, film coated in 1 bottle | 65162-058-09 | — | 28 November 2017 |
| 1000 tablet, film coated in 1 bottle | 65162-058-11 | — | 28 November 2017 |
| 270 tablet, film coated in 1 bottle | 65162-058-27 | — | 28 November 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sevelamer 800 mg tablet.
Other strengths and forms of Sevelamer
Clinical summary
Sevelamer is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. MedsAcross supplies Sevelamer for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SevelamerFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Renvela prescribing information (Genzyme) · U.S. National Library of Medicine, DailyMed
- Renagel: European public assessment report (EPAR) · European Medicines Agency
- Renvela: European public assessment report (EPAR) · European Medicines Agency
Need Sevelamer 800 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.